Sign in
Active, not recruitingNo phase

Mirror Medacta Shoulder System Pivotal Trial

Key facts

Who runs it
Medacta International SA
Where
Switzerland2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
5 Jan 2022
Expected to end
28 Feb 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mirror Medacta Shoulder System
  • Medacta Shoulder System
Record updated
7 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (21)Hide the full registry criteria

Who can take part

  • Age ≥ 18 yr
  • Clinical indication for anatomic primary total shoulder replacement due to osteoarthritis and/or posttraumatic arthritis
  • Willingness and ability to comply with study protocol

Who cannot take part

  • Prior rotator cuff surgery
  • Insufficient bone quality which may affect the stability of the implant
  • Chemotherapy treatment/radiotherapy within 6 mo before surgery
  • >5 mg/day of corticosteroids, excluding inhalers, within 3 years before surgery
  • Alcohol or drug abuse
  • Previous or current infection at or near the site of implantation
  • Medical condition or balance impairment that could lead to falls
  • Active metastatic or neoplastic disease at the shoulder joint
  • Inability to understand study or a history of noncompliance with medical advice
  • Metal allergies or sensitivity
  • Current distant or systemic infection
  • ONLY for women of childbearing age: a positive pregnancy test (urine / blood)
  • Cuff tear arthropathy/insufficient rotator cuff
  • Neuromuscular compromise of shoulder or other disabilities affecting the maximum functional outcomes
  • Weight bearing shoulder due to wheel chair, crutches, rollator at the time of operation
  • Pregnancy or plan to become pregnant during study period
  • Current enrollment in any clinical research study that might interfere with this study
  • Patient, whose infomed consent form should be taken in an emergency situation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

The 2 groups in the trial

  • Mirror groupTreatment being tested

    Mirror Medacta Shoulder System

    Treatment: Mirror Medacta Shoulder System

  • Historical Control groupExisting treatment, for comparison

    Total shoulder arthroplasty system

    Treatment: Medacta Shoulder System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multicentric, Prospective, Comparative Trial to Assess the Efficacy and Safety of an Anatomic Total Shoulder System.
Record updated
7 October 2026